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Abstract
Background: Supervised classification is fundamental in bioinformatics. Machine learning models,
such as neural networks, have been applied to discover genes and expression patterns. This
process is achieved by implementing training and test phases. In the training phase, a set of cases
and their respective labels are used to build a classifier. During testing, the classifier is used to
predict new cases. One approach to assessing its predictive quality is to estimate its accuracy during
the test phase. Key limitations appear when dealing with small-data samples. This paper investigates
the effect of data sampling techniques on the assessment of neural network classifiers.
Results:  Three data sampling techniques were studied: Cross-validation, leave-one-out, and
bootstrap. These methods are designed to reduce the bias and variance of small-sample
estimations. Two prediction problems based on small-sample sets were considered: Classification
of microarray data originating from a leukemia study and from small, round blue-cell tumours. A
third problem, the prediction of splice-junctions, was analysed to perform comparisons. Different
accuracy estimations were produced for each problem. The variations are accentuated in the small-
data samples. The quality of the estimates depends on the number of train-test experiments and
the amount of data used for training the networks.
Conclusion: The predictive quality assessment of biomolecular data classifiers depends on the
data size, sampling techniques and the number of train-test experiments. Conservative and
optimistic accuracy estimations can be obtained by applying different methods. Guidelines are
suggested to select a sampling technique according to the complexity of the prediction problem
under consideration.
Background
Supervised classification plays a key role in bioinformat-
ics. One such application is the recognition of expression
patterns for disease classification and gene function dis-
covery [1,2]. It requires the construction of a model,
which processes input vectors representing cases, and pre-
dicts the class or category associated to the cases under
consideration. A class may represent, for example, a type
of cancer or a biological function [3,4]. This recognition
process is achieved by implementing training and test phas-
es. In the training phase, also known as the learning phase,
a set of cases and their respective labels are used to build
a classification model. In the test or validation phase, the
trained classifier is used to predict new cases. Artificial
neural networks (ANNs), such as the back-propagation
feed-forward neural network (BP-ANN) [5] have become
useful tools to perform classification applications in func-
tional genomics, [6]. An ANN may be trained, for
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instance, to differentiate genes or experiments by adapting
mathematical structures known as weights. This process
aims to optimise the prediction of classes for each case in
the training set. Generalisation is the ability to correctly
classify cases unseen during training. ANNs have been
successful in a number of diagnostic, prognostic and sys-
tems biology applications [2,7]. The reader is referred to
[7] for a review on neural networks and their applications
in functional genomics.
One basic approach to assessing the predictive quality of
a classifier is to estimate its accuracy during the test phase.
Ideally an ANN classifier will be able to generalise if: a) its
architecture and learning parameters have been properly
defined, and b) enough training data are available. Never-
theless, the second condition is difficult to achieve due to
resource and time constraints. Key limitations appear
when dealing with small-data samples, which is a com-
mon feature observed in many microarray studies [7,8].
With a small training dataset, an ANN may not be able to
accurately represent the data under analysis. Similarly, a
small test dataset may contribute to an inaccurate per-
formance assessment. Moreover, this accuracy estimation
task may have a strong impact on the selection of features
for knowledge discovery applications [8].
These factors are relevant for expression data classification
and other genomic studies because: a) the biological
problems under analysis are complex, and b) the available
data are limited, incomplete and inaccurate. Solutions
have been proposed to address the processing of incom-
plete and inaccurate data [7]. Small sample issues and the
estimation of the prediction accuracy of classifiers have re-
ceived relatively little attention [2,8]. Scientists have tradi-
tionally dealt with the problem of limited data by
carefully selecting relevant cases for training and testing
[8]. However, the complexity of most classification tasks
and the underlying biological problems require the im-
plementation of automated, effective and efficient solu-
tions to reduce the bias and variance contributions from
small datasets.
There are three techniques to estimate the prediction accu-
racy of classifiers such as ANNs: a) cross-validation, b) leave-
one-out, and c) bootstrap. They comprise different methods
for splitting or sampling the data. These techniques have
demonstrated the reduction of either the estimation bias
or the variance introduced by a small dataset [9].
The cross-validation method [10] randomly divides the
data into the training and test sets. This process is repeated
several times and the classification performance is the av-
erage of the individual test estimates. However, the classi-
fier may not be able to accurately predict new cases if the
amount of data used for training is too small. At the same
time, the quality assessment may not be accurate if the
portion of data used for testing is too small. This sampling
technique has been studied in regression and classifica-
tion tasks for engineering and medical informatics appli-
cations [11,12]. Some investigations have suggested a
split between 25%–50% of the available data as an opti-
mal partition for testing [9].
The Leave-one-out method represents a special case of the
cross-validation technique [11]. Given n cases available in
a dataset, a classifier is trained on (n-1) cases, and then is
tested on the case that was left out. This process is repeated
n times until every case in the dataset has been included
once as a cross-validation instance. The results are aver-
aged across the n test cases to estimate the classifier's pre-
diction performance.
In the bootstrap method a training dataset is generated by
sampling with replacement n times from the available n
cases [13]. The classifier is trained on this set and then
tested on the original dataset. This process is repeated sev-
eral times, and the classifier's accuracy estimate is the av-
erage of these individual estimates.
This paper investigates the effect of data sampling tech-
niques on the performance assessment of BP-ANN classi-
fiers for biomolecular data. Two small-sample datasets
were analysed: Microarray data originating from a study
on leukaemia, and microarray data originating from
small, round blue-cell tumours (SRBCT). A larger dataset
consisting of splice-junctions gene sequences was ana-
lysed to perform comparisons.
The main research goals of this study are: a) to establish
differences between data sampling techniques when ap-
plied to small and larger datasets, b) to study the response
of these methods to the size and number of train-test sets,
and c) to investigate criteria for the selection of sampling
techniques.
Results
The prediction accuracy of each classification model was
assessed by applying the sampling techniques and moni-
toring its response to several thousands train-test experi-
ments. The classification accuracy of an individual
experiment is defined as the proportion of correctly classi-
fied cases of all cases available. Several thousand BP-
ANNs were trained and tested on the datasets described
above.
Classification of expression patterns in a leukaemia study
The data consisted of 72 cases categorised into two classes:
Acute myeloid leukemia (AML) and acute lymphoblastic leuke-
mia (ALL), which are represented by the expression values
of 50 genes with suspected roles in processes relevant toBMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/5
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these diseases. These classes included 25 and 47 cases re-
spectively. The original datasets, experimental protocols
and further analyses can be found in [14] and at the MIT
Whitehead Institute Web site http://www.ge-
nome.wi.mit.edu/MPR. All of the networks were trained
and tested using the same learning parameters. The BP-
ANN architectures comprised 50 input nodes, 5 hidden
nodes and 2 output nodes. Each output node encodes one
of the leukaemia classes.
In this study, the cross-validation results were analysed for
three different data splitting methods: a) 50% of the avail-
able cases were used for training the classifiers and the re-
maining 50% for testing, b) 75% for training and 25% for
testing, and c) 95% for training and 5% for testing. Figures
1, 2 and 3 show the prediction accuracy values and their
confidence intervals (95% confidence) obtained for each
splitting technique respectively. Figure 1 indicates that
more than 500 train-test runs are required to significantly
reduce the variance of these estimates (confidence interval
size for the mean equal to 0.01). The smallest numbers of
train-test experiments allow the generation of the highest
or most optimistic accuracy estimates. This method pro-
duced the lowest (most conservative) cross-validation ac-
curacy estimates. Figure 2 shows that more than 1000
train-test runs are required to significantly reduce the var-
iance of this cross-validation estimate. Again, the smallest
numbers of train-test experiments generated the most op-
timistic accuracy estimates. The 95%–5% cross-validation
method (Figure 3) requires more than 5000 train-test runs
to reduce the variance of these estimates. This method
produced the most optimistic cross-validation accuracy
estimates. The leave-one-out method estimated the high-
est prediction accuracy for this classification problem
(0.81). The results generated by the bootstrap method are
depicted in Figure 4. It indicates that more than 1000
train-test runs were required to achieve a confidence inter-
val size equal to 0.01. The bootstrap result originating
from 1000 train-test runs is not significantly different than
that produced by the 50%–50% cross-validation tech-
nique based on 1000 train-test runs. These results suggest
that the estimation of high accuracy values may be associ-
ated with an increase of the size of the training datasets.
Classification of expression patterns in SRBCT
The data consisted of 88 cases categorised into four class-
es:  Ewing family of tumors (EWS),  rhabdomyosarcoma
(RMS), Burkitt lymphomas (BL) and neuroblastomas (NB),
which were represented by the expression values of 2308
genes with suspected roles in processes relevant to these
tumors. Classes EWS, BL, NB and RMS contained 30, 11,
19 and 28 cases respectively. Principal component
Figure 1
Accuracy estimation for leukaemia data classifier (I) 
Cross-validation method based on a 50%–50% splitting. Pre-
diction accuracy values and the confidence intervals for the 
means (95% confidence) are depicted for a number of train-
test runs. A: 10 train-test runs, B: 25 train-test runs, C: 50 
train-test runs, D: 100 train-test runs, E: 500 train-test runs, 
F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
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Figure 2
Accuracy estimation for leukaemia data classifier (II) 
Cross-validation method based on a 75%–25% splitting. Pre-
diction accuracy values and the confidence intervals for the 
means (95% confidence) are depicted for a number of train-
test runs. A: 10 train-test runs, B: 25 train-test runs, C: 50 
train-test runs, D: 100 train-test runs, E: 500 train-test runs, 
F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
ABCDEFGHI J
Train-test runs
0.70
0.72
0.74
0.76
0.78
0.80
0.82
0.84
0.86
0.88
0.90
0.92
0.94
C
l
a
s
s
i
f
i
c
a
t
i
o
n
 
a
c
c
u
r
a
c
yBMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/5
Page 4 of 14
(page number not for citation purposes)
analysis was applied to reduce the dimensionality of the
cases. As indicated in [6], the 10 dominant components
per case were used to train the networks. The original da-
tasets, experimental protocols and further analyses can be
found in [6]. All of the networks were trained and tested
using the same learning parameters. The BP-ANN archi-
tectures comprised 10 input nodes, 8 hidden nodes and 4
output nodes. Each output node encodes one of the tu-
mor classes.
Figures 5, 6 and 7 illustrate the prediction accuracy mean
values and their confidence intervals (95% confidence)
obtained for each cross-validation technique respectively.
Figure 5 indicates that more than 500 train-test runs are
required to achieve a confidence interval size equal to
0.01 for this splitting method. The smallest numbers of
train-test experiments allow the generation of the most
optimistic accuracy estimates. However, in general this
method produced the most conservative cross-validation
accuracy estimates. Figure 6 shows that more than 1000
train-test runs are required to significantly reduce the var-
iance of this cross-validation estimate. The 95%–5%
cross-validation method (Figure 7) requires more than
5000 train-test runs to achieve the same. This method pro-
duced the most optimistic cross-validation accuracy esti-
mates. The leave-one-out method produced the highest
accuracy estimate for this dataset (0.79). Figure 8 illus-
trates the results generated by the bootstrap method. In
this situation more than 900 train-test runs were required
to achieve a confidence interval size equal to 0.01. These
results also suggest that the estimation of high accuracy
values may be linked to an increase of the size of the train-
ing datasets.
Classification of splice-junction sequences
This dataset consisted of 2000 cases divided into three cat-
egories: Exon/intron boundaries (EI), intron/exon boundaries
(IE) and neither (N). Each class comprised 464, 485 and
1051 cases respectively. Each case is represented by 60 fea-
tures, which encode the nucleotide composition of each
sequence.
The original datasets and further information can be ob-
tained at: http://www.liacc.up.pt/ML/statlog/datasets/
dna/dna.doc.html.
Each BP-ANN consisted of 60 input nodes, 10 hidden
nodes and 3 output nodes. The sampling techniques gen-
erated different accuracy estimates. But unlike the
expression datasets, there were relatively less significant
differences between methods. There are not significant
statistical differences between the estimates produced by
the train-test experiments belonging to a particular data
sampling method. Moreover, less train-test runs are re-
quired to reduce the variance of the cross-validation and
Figure 3
Accuracy estimation for leukaemia data classifier 
(III) Cross-validation method based on a 95%–5% splitting. 
Prediction accuracy values and the confidence intervals for 
the means (95% confidence) are depicted for a number of 
train-test runs. A: 10 train-test runs, B: 25 train-test runs, C: 
50 train-test runs, D: 100 train-test runs, E: 500 train-test 
runs, F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
Figure 4
Accuracy estimation for leukaemia data classifier 
(IV) Bootstrap method. Prediction accuracy values and the 
confidence intervals for the means (95% confidence) are 
depicted for a number of train-test runs. A: 100 train-test 
runs, B: 200 train-test runs, C: 300 train-test runs, D: 400 
train-test runs, E: 500 train-test runs, F: 600 train-test runs, 
G: 700 train-test runs, H: 800 train-test runs, I: 900 train-test 
runs, J: 1000 train-test runs.
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Figure 5
Accuracy estimation for the SRBCT classifier (I) 
Cross-validation method based on a 50%–50% splitting. Pre-
diction accuracy values and the confidence intervals for the 
means (95% confidence) are depicted for a number of train-
test runs. A: 10 train-test runs, B: 25 train-test runs, C: 50 
train-test runs, D: 100 train-test runs, E: 500 train-test runs, 
F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
Figure 6
Accuracy estimation for the SRBCT classifier (II) 
Cross-validation method based on a 75%–25% splitting. Pre-
diction accuracy values and the confidence intervals for the 
means (95% confidence) are depicted for a number of train-
test runs. A: 10 train-test runs, B: 25 train-test runs, C: 50 
train-test runs, D: 100 train-test runs, E: 500 train-test runs, 
F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
ABCDEFGHI J
Train-test runs
0.71
0.72
0.73
0.74
0.75
0.76
0.77
0.78
0.79
0.80
0.81
C
l
a
s
s
i
f
i
c
a
t
i
o
n
 
a
c
c
u
r
a
c
y
ABCDEFGHI J
Train-test runs
0.71
0.72
0.73
0.74
0.75
0.76
0.77
0.78
0.79
0.80
C
l
a
s
s
i
f
i
c
a
t
i
o
n
 
a
c
c
u
r
a
c
y
Figure 7
Accuracy estimation for the SRBCT classifier (III) 
Cross-validation method based on a 95%–5% splitting. Pre-
diction accuracy values and the confidence intervals for the 
means (95% confidence) are depicted for a number of train-
test runs. A: 10 train-test runs, B: 25 train-test runs, C: 50 
train-test runs, D: 100 train-test runs, E: 500 train-test runs, 
F: 1000 train-test runs, G: 2000 train-test runs, H: 3000 
train-test runs, I: 4000 train-test runs, J: 5000 train-test runs.
Figure 8
Accuracy estimation for the SRBCT classifier (IV) 
Bootstrap method. Prediction accuracy values and the confi-
dence intervals for the means (95% confidence) are depicted 
for a number of train-test runs. A: 100 train-test runs, B: 200 
train-test runs, C: 300 train-test runs, D: 400 train-test runs, 
E: 500 train-test runs, F: 600 train-test runs, G: 700 train-test 
runs, H: 800 train-test runs, I: 900 train-test runs, J: 1000 
train-test runs.
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bootstraps estimates. Figures 9, 10 and 11 portray the
mean accuracy estimates and their confidence intervals
(95% confidence) obtained for each cross-validation tech-
nique respectively. Figure 9 indicates that more than 300
train-test runs are required to significantly reduce the var-
iance of the 50%–50% cross-validation estimates. Howev-
er, a confidence interval size equal to 0.01 had been
achieved earlier for only 50 runs. In general this method
produced the most conservative cross-validation accuracy
estimates. Figure 10 shows that only 50 train-test runs are
required to significantly reduce the variance of the 75%–
25% cross-validation estimates. The 95%–5% cross-vali-
dation method (Figure 11) needed only 100 train-test
runs to achieve the same. This splitting method generated
one of the most optimistic accuracy estimates for this da-
taset. The leave-one-out method also produced one of
highest accuracy estimates for this problem (0.97). There
are not significant differences between the accuracy esti-
mates produced by these two methods. Finally, Figure 12
illustrates the results generated by the bootstrap tech-
nique. In this method only 100 train-test runs were
required to significantly reduce the variance of the
estimates.
The results originating from each sampling method and
dataset are summarised in Tables 1 to 4. Tables 1, 2 and 3
compare the cross-validation results for the leukaemia,
SRBCT and splice-junction datasets respectively. Table 4
summarises the bootstrap technique results.
Discussion
The assessment of classification performance is a crucial
problem. Nevertheless, relatively little attention has been
given to this problem in bioinformatics [8]. There is
special concern in application domains, such as microar-
ray data analysis, which have been based on the process-
ing of relatively small datasets.
ANNs have become useful tools to assist several classifica-
tion functions in genomic expression studies. A key prob-
lem is to determine the optimal amount of data required
for both properly training the classifier and accurately
estimating its predictive accuracy. In expression analysis,
like in many other applications in biosciences, such an
optimal solution is unknown. Moreover, this is difficult to
estimate due to the limited size of the datasets available.
Previous studies have addressed these issues in engineer-
ing and medical informatics applications [12,13].
Figure 9
Accuracy estimation for the splice-junction sequence 
classifier (I) Cross-validation method based on a 50%–50% 
splitting. Prediction accuracy values and the confidence inter-
vals for the means (95% confidence) are depicted for a 
number of train-test runs. A: 10 train-test runs, B: 25 train-
test runs, C: 50 train-test runs, D: 100 train-test runs, E: 200 
train-test runs, F: 300 train-test runs, G: 400 train-test runs, 
H: 500 train-test runs, I: 800 train-test runs, J: 1000 train-test 
runs.
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Figure 10
Accuracy estimation for the splice-junction sequence 
classifier (II) Cross-validation method based on a 75%–25% 
splitting. Prediction accuracy values and the confidence inter-
vals for the means (95% confidence) are depicted for a 
number of train-test runs. A: 10 train-test runs, B: 25 train-
test runs, C: 50 train-test runs, D: 100 train-test runs, E: 200 
train-test runs, F: 300 train-test runs, G: 400 train-test runs, 
H: 500 train-test runs, I: 800 train-test runs, J: 1000 train-test 
runs.
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In this paper, three sampling techniques were implement-
ed to assess the classification accuracy of ANNs in three
genomic data analysis problems. It shows that in general
there is variability among the three techniques. However,
these experiments suggest that it is possible to achieve
lower variance estimates for different numbers of train-
test runs. Furthermore, one may identify conservative and
optimistic accuracy predictors, whose overall estimates
Figure 11
Accuracy estimation for the splice-junction sequence 
classifier (III) Cross-validation method based on a 95%–5% 
splitting. Prediction accuracy values and the confidence inter-
vals for the means (95% confidence) are depicted for a 
number of train-test runs. A: 10 train-test runs, B: 25 train-
test runs, C: 50 train-test runs, D: 100 train-test runs, E: 200 
train-test runs, F: 300 train-test runs, G: 400 train-test runs, 
H: 500 train-test runs, I: 800 train-test runs, J: 1000 train-test 
runs.
Figure 12
Accuracy estimation for the splice-junction sequence 
classifier (IV) Bootstrap method. Prediction accuracy val-
ues and the confidence intervals for the means (95% confi-
dence) are depicted for a number of train-test runs. A: 100 
train-test runs, B: 200 train-test runs, C: 300 train-test runs, 
D: 400 train-test runs, E: 500 train-test runs, F: 600 train-test 
runs, G: 700 train-test runs, H: 800 train-test runs, I: 900 
train-test runs, J: 1000 train-test runs.
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Figure 13
Mean square error during training for a leukaemia 
classifier (I) 50%–50% data splitting.
Figure 14
Mean square error during training for a leukaemia 
classifier (II) 75%–25% data splitting.
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may be significantly different. This effect is more distin-
guishable in small-sample applications.
For both expression datasets, the more conservative pre-
dictions were generated by the 50%–50% cross-validation
and bootstrap methods. In the leukaemia classification
problem, both methods require the same number of train-
test experiments (1000) to significantly reduce the vari-
ance of their estimates. The estimates produced by such
conservative classifiers were not significantly different. In
the SRBCT classification task, the predictions generated by
those methods were significantly different (t-tests,  p  <
0.01). However, they needed a similar number of train-
test experiments to provide low variance estimates. The
most optimistic estimates were produced by the 95%–5%
cross-validation and leave-one-out techniques. Their ac-
curacy estimates were not significantly different in both
data classification problems.
Figure 15
Mean square error during training for a leukaemia 
classifier (III) 95%–5% data splitting.
Figure 16
Mean square error during training for a leukaemia 
classifier (IV) Leave-one-out data splitting.
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Figure 17
Entropy error during training for a SRBCT classifier 
(I) 50%–50% data splitting.
Figure 18
Entropy error during training for a SRBCT classifier 
(II) 75%–5% data splitting.
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The predicted accuracy of a classifier is generally propor-
tional to the size of the training dataset. However, one of
the reviewers of this paper has pointed out that the pre-
dicted accuracies for the leukaemia models increase little
as the splits varies from 50%–50% trough 75%–25% to
95%–5%. The reviewer indicated that this may occur
because some of the observations in the dataset may be
considered as atypical, which has been reported by Golub
and colleagues [14].
A larger dataset consisting of DNA splice-junction se-
quences was analysed in order to identify possible
differences relating to the train-test data size factor. These
classifiers were built on a more robust dataset. Therefore,
the estimates generated by the sampling techniques are
relatively similar. Like in the case of the expression data
classification applications, the 50%–50% cross-validation
and bootstrap methods produced the most conservative
estimates. The most optimistic estimates were again
Figure 19
Entropy error during training for a SRBCT classifier 
(III) 95%–5% data splitting.
Figure 20
Entropy error during training for a SRBCT classifier 
(IV) Leave-one-out data splitting.
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Figure 21
Entropy error during training for a splice-junction 
classifier (I) 50%–50% data splitting.
Figure 22
Entropy error during training for a splice-junction 
classifier (II) 75%–5% data splitting.
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provided by the 95%–5% cross-validation and leave-one-
out techniques. There was a significant difference (t-tests,
p < 0.05) between the lowest variance estimates generated
by the bootstrap and the 95%–5% cross-validation
methods. There were not significant differences between
the most conservative approaches, and between the most
optimistic approaches. Nevertheless, there are differences
in terms of the number of train-test experiments required
to reduce variability. In this problem, the leave-one-out
method consists of 2000 train-test runs. The 95%–5%
only requires 100 train-test runs to produce low variance
estimates. Regarding the conservative accuracy classifiers:
The 50%–50% cross-validation method may achieve low
accuracy variability with 300 train-test experiments; the
bootstrap method required at least 100 runs.
In general, the cross-validation results suggest that the
classification accuracy estimates may increase when there
is an increase in the size of the training dataset. Moreover,
when the amount of testing data is reduced, more train-
test data partitions are needed to achieve low variance
estimates.
Previous research has indicated that the leave-one-out
method may effectively address the problem of processing
small datasets, due to its capability to process almost all of
the available data for training the classifier. Overall, this
method produced the highest accuracy estimates for the
classification problems discussed here.
This study indicates that the bootstrap method may be ap-
plied to generate conservative and robust accuracy
estimates, based on a relatively small number of train-test
experiments.
Predicting the "true" accuracy of a classification approach
is a complex and time-consuming problem. This type of
analyses may be especially relevant to the development of
more rigorous and reliable microarray data interpretation
systems. This study may be benefited from the integration
of alternative tools to visualise or measure classification
performance [8,13].
There is a need to provide better insights into the process
of evaluating the predictive capability of diagnostic and
prognostic systems [8,15]. Future research should
compare different classification approaches, including
unsupervised methods [14]. Moreover, it will be
important to have access to expression datasets compris-
ing thousands of cases. Other important issues that
deserve investigation are: The determination of
relationships between data sampling techniques and fea-
ture selection methods, and the combination of multiple
sampling techniques to produce more robust and reliable
accuracy estimates.
Conclusions
This research suggests that, at least in the case of small ex-
pression datasets, thousands of train-test runs may be
required to produce low variance performance predic-
tions. Moreover, there may be differences among the esti-
mates produced by different techniques. The results show
that the 50%–50% cross-validation and bootstrap
methods provide the most conservative estimates. Leave-
Figure 23
Entropy error during training for a splice-junction 
classifier (III) 95%–5% data splitting.
Figure 24
Entropy error during training for a splice-junction 
classifier (IV) Leave-one-out data splitting.
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one-out and 95%–5% cross-validation techniques gener-
ate the highest accuracy predictions. In comparison to
other sampling techniques, the bootstrap method may re-
quire a small number of train-test experiments to produce
low variance estimates. For datasets consisting of thou-
sands of cases, a 95%–5% cross-validation procedure may
be the best choice to achieve optimistic and low variance
results, based on a relatively small number of train-test
experiments.
The identification of the best sampling technique for the
prediction of classification accuracy is a complex task.
This problem, which has not been adequately studied by
the bioinformatics community, may influence the out-
Table 1: Summary of cross-validation results for leukaemia data: Mean ± standard error of classification accuracies
Train/test runs 50%–50% cross validation 75%–25% cross validation 95%–5% cross validation
10 0.786 ± 0.0176 0.844 ± 0.0319 0.775 ± 0.0583
25 0.760 ± 0.0149 0.804 ± 0.0225 0.730 ± 0.0477
50 0.732 ± 0.0117 0.763 ± 0.0164 0.735 ± 0.0306
100 0.725 ± 0.0083 0.744 ± 0.0125 0.750 ± 0.0213
500 0.736 ± 0.0033 0.764 ± 0.0049 0.770 ± 0.0093
1000 0.740 ± 0.0025 0.766 ± 0.0034 0.770 ± 0.0066
2000 0.739 ± 0.0018 0.764 ± 0.0024 0.768 ± 0.0048
3000 0.738 ± 0.0015 0.762 ± 0.0019 0.767 ± 0.0038
4000 0.740 ± 0.0013 0.762 ± 0.0017 0.770 ± 0.0033
5000 0.741 ± 0.0011 0.762 ± 0.0015 0.771 ± 0.0029
Table 2: Summary of cross-validation results for SRBCT data: Mean ± standard error of classification accuracies
Train/test runs 50%–50% cross validation 75%–25% cross validation 95%–5% cross validation
10 0.768 ± 0.0169 0.755 ± 0.0169 0.750 ± 0.0745
25 0.747 ± 0.0112 0.749 ± 0.0134 0.740 ± 0.0444
50 0.737 ± 0.0076 0.759 ± 0.0102 0.745 ± 0.0281
100 0.734 ± 0.0059 0.750 ± 0.0079 0.733 ± 0.0202
500 0.733 ± 0.0031 0.749 ± 0.0039 0.747 ± 0.0097
1000 0.732 ± 0.0021 0.752 ± 0.0027 0.749 ± 0.0068
2000 0.734 ± 0.0014 0.748 ± 0.0019 0.751 ± 0.0047
3000 0.733 ± 0.0012 0.749 ± 0.0016 0.758 ± 0.0038
4000 0.733 ± 0.0010 0.747 ± 0.0014 0.760 ± 0.0033
5000 0.733 ± 0.0009 0.746 ± 0.0012 0.761 ± 0.0030
Table 3: Summary of cross-validation results for splice-junction sequence data: Mean ± standard error of classification accuracies
Train/test runs 50%–50% cross validation 75%–25% cross validation 95%–5% cross validation
10 0.940 ± 0.0051 0.962 ± 0.0032 0.969 ± 0.0050
25 0.952 ± 0.0035 0.964 ± 0.0026 0.970 ± 0.0036
50 0.953 ± 0.0024 0.964 ± 0.0020 0.968 ± 0.0027
100 0.953 ± 0.0050 0.967 ± 0.0014 0.971 ± 0.0020
500 0.956 ± 0.0026 0.966 ± 0.0010 0.969 ± 0.0013
1000 0.957 ± 0.0019 0.968 ± 0.0008 0.969 ± 0.0011
2000 0.957 ± 0.0019 0.968 ± 0.0007 0.969 ± 0.0009
3000 0.958 ± 0.0016 0.966 ± 0.0007 0.968 ± 0.0014
4000 0.959 ± 0.0010 0.968 ± 0.0005 0.969 ± 0.0010
5000 0.957 ± 0.0009 0.968 ± 0.0005 0.970 ± 0.0008BMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/5
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comes of many tasks in biomedical research. The selection
of a sampling technique will depend on the complexity of
the application domain and the amount of data available.
Another key issue that need to be carefully investigated is
its relationship to feature selection.
This paper highlights the importance of performing more
rigorous procedures on the selection of data and
classification quality assessment. However, studies con-
sisting of additional datasets and classification models are
needed to recommend generic frameworks for the selec-
tion of data sampling techniques. This research may also
be improved by applying more robust performance
evaluation tools, such as receiver operating characteristic
curves.
In general the application of more than one sampling
technique may provide the basis for accurate and reliable
predictions. A scientist may be more confident about the
performance estimates if similar results are obtained by
executing different techniques.
Methods
Data
The leukaemia data consisted of 72 cases categorised into
two classes: Acute myeloid leukemia (AML) and acute lym-
phoblastic leukemia (ALL), which were represented by the
expression values of 50 genes with suspected roles in proc-
esses relevant to these diseases. These classes included 25
and 47 cases respectively. The original datasets, experi-
mental protocols and further analyses can be found in
[13] and at the MIT Whitehead Institute Web site http://
www.genome.wi.mit.edu/MPR.
The SRBCT data consisted of 88 cases categorised into four
classes: Ewing family of tumors (EWS), rhabdomyosarcoma
(RMS), Burkitt lymphomas (BL) and neuroblastomas (NB),
which were represented by the expression values of 2308
genes with suspected roles in processes relevant to these
tumors. Classes EWS, BL, NB and RMS contained 30, 11,
19 and 28 cases respectively. The original datasets, exper-
imental protocols and further analyses can be found at the
NHGRI  Web site: http://research.nhgri.nih.gov/microar-
ray/.
The splice-junction data consisted of 2000 sequences di-
vided into three categories: Exon/intron boundaries (EI), in-
tron/exon boundaries (IE) and neither  (N). Each class
comprised 464, 485 and 1051 cases respectively. Each
case is represented by 60 features, which encode the nu-
cleotide composition of each sequence based on a binary
scheme. It uses 3 binary bits to represent each sequence
base in the original data.
The original datasets and further information can be ob-
tained at: http://www.liacc.up.pt/ML/statlog/datasets/
dna/dna.doc.html.
Data preparation
Before training the networks the leukaemia expression
data were normalised using the well known minimax tech-
nique. The dimensionality of the SRBCT expression
samples was reduced by applying Principal Component
Analysis (PCA). The 10 dominant PCA components for
each case were used as the input to the classifiers as sug-
gested by [6]. The 60 binary features representing each
splice-junction sequence were used to train the networks
without additional pre-processing.
Network architectures and training
All of the networks were trained with the Back Propaga-
tion algorithm. A learning epoch is defined as a single pass
thorough the entire dataset. The learning stopping
condition was based on the minimum improvement of
error. In this method a training process is stopped if the
classification performance (based on the sum-squared er-
ror or entropy function [12]) deteriorates for a number of
learning epochs (the learning window). When training is
Table 4: Summary of bootstrap method results for three datasets: Mean ± standard error of classification accuracies
Train/test runs Leukaemia SRBCT Splice-junctions
100 0.743 ± 0.0108 0.753 ± 0.0074 0.965 ± 0.0014
200 0.736 ± 0.0078 0.741 ± 0.0057 0.962 ± 0.0011
300 0.738 ± 0.0062 0.740 ± 0.0044 0.960 ± 0.0009
400 0.739 ± 0.0053 0.740 ± 0.0038 0.961 ± 0.0007
500 0.742 ± 0.0047 0.741 ± 0.0033 0.960 ± 0.0007
600 0.742 ± 0.0042 0.744 ± 0.0030 0.962 ± 0.0006
700 0.743 ± 0.0039 0.745 ± 0.0028 0.961 ± 0.0006
800 0.744 ± 0.0035 0.746 ± 0.0026 0.961 ± 0.0006
900 0.746 ± 0.0033 0.746 ± 0.0024 0.961 ± 0.0005
1000 0.746 ± 0.0032 0.746 ± 0.0023 0.961 ± 0.0005BMC Bioinformatics 2003, 4 http://www.biomedcentral.com/1471-2105/4/5
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stopped the best network found during training is pre-
served and included in the analyses.
The leukaemia data networks consisted of 50 input nodes,
5 hidden nodes and 2 outputs. They were trained during
100 learning epochs based on the sum-squared error func-
tion. The size of the learning window was equal to 5.
The SRBCT networks comprised 10 input nodes, 8 hidden
nodes and 4 outputs. They were trained during 300
learning epochs based on the entropy error function. The
size of the learning window was equal to 10.
The splice-junction sequence networks had 60 input
nodes, 10 hidden nodes and 4 outputs. They were trained
during 100 learning epochs based on the entropy error
function. The size of the learning window was equal to 5.
The networks and sampling methods were implemented
using the package Statistica™.
Sampling methods
For each train-test run, a classification accuracy value is
predicted. The accuracy value for a particular train-test run
is equal to the number of test cases correctly classified
divided by the total number of test cases. For a set of train-
test runs, for instance 100 or 1000 train-test runs, a mean
accuracy value is calculated. Confidence intervals are then
calculated for each mean. In this case, the 95 percent con-
fidence interval is approximated with the mean plus or
minus twice the standard error of the mean.
The author would like to state that the standard errors
have been calculated on the basis that the runs are inde-
pendent, which is an assumption that may not exactly
hold in practice.
The accuracy values estimated for the train-test runs are as-
sumed to be independent. It is supposed that the occur-
rence of each test accuracy value does not affect the
occurrence or non-occurrence of the other test accuracy
values. This is because the random sampling is performed
with replacement. After a test dataset is selected and the
classifier accuracy is evaluated, the test dataset is restored
to the original dataset, and the whole dataset is shuffled.
Thus, one may assume that each train-test run becomes
independent of the previous sampling.
Even when different classifiers will be based on training
and test datasets with observations in common, one
assumes that their estimated classification accuracies are
independent. That is because the probability of including
a case, x, in the training (or test) dataset of the current
train-test experiment is equal to the probability of includ-
ing the same case, x, in the training (or test) dataset of the
next train-test experiment.
In the cross-validation method the data is randomly di-
vided into the training and test sets. This process is repeat-
ed several times and the classification performance is the
average of the individual test estimates. In the leave-one-
out method: Given n cases available in each dataset, a clas-
sifier is trained on (n-1) cases, and then is tested on the
case that was left out. This process is repeated n times until
every case in the dataset was included once as a cross-val-
idation instance. For each classifier, the results were aver-
aged across the n  test cases to estimate the classifier's
prediction performance. In the bootstrap method, a train-
ing dataset was generated by sampling with replacement n
times from the available n cases. Each classifier is trained
on the resulting set and then tested on the original dataset.
This process is repeated several times, and the classifier's
accuracy estimate is equal to the average of these individ-
ual estimates.
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